EuroNeut41: Safety & Immunogenicity of Immunisations With HIV Vaccine

NCT01509144 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV

Interventions

BIOLOGICAL: EN41-FPA2 HIV vaccine
BIOLOGICAL: EN41-FPA2 HIV vaccine
BIOLOGICAL: EN41-FPA2 HIV vaccine
BIOLOGICAL: EN41-FPA2 HIV vaccine
BIOLOGICAL: Na Cl Placebo vaccine

Sponsor

PX'Therapeutics

Collaborators

[object Object]